Reproducibility of Peak Oxygen Uptake and Other Cardiopulmonary Exercise Parameters
The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
Abstract
Background Clinical trialists involved in projects aimed at assessing the impact of a device or therapy on exercise capacity must select an end point that can detect a therapy-derived change and do so in a manner that is both sensitive to the change and valid. Using baseline data from the Prospective Evaluation of Elastic Restraint to Lessen the Effects of Heart Failure (PEERLESS-HF) trial, we describe the coefficient of variation (CV) for peak oxygen uptake (Vo2) and other parameters measured during a cardiopulmonary exercise (CPX) test.Methods Prior to conducting CPX testing, a CPX core laboratory conducted training with testing staff at each site, and a standardized quality assurance protocol was completed. During screening, subjects performed two symptom-limited CPX tests (CPX-0 and CPX-1) within 14 days.Results The CVs for peak Vo2, ventilatory efficiency, and ventilatory-derived anaerobic threshold were 5.9%, 4.8%, and 6.8%, respectively. During CPX-0, the percentage of subjects with a respiratory exchange ratio (RER) < 1.05 who increased their peak Vo2 by ≥ 6% during CPX-1 was 47%, compared with 12% of subjects also with an RER < 1.05 who experienced a decrease in peak Vo2 ≥ 6%.Conclusions In a multisite clinical trial setting, we showed that the achieved test-retest reproducibility for peak Vo2 can be acceptable, as evidenced by a CV at 5.9%. Until more data are available to identify patients who may demonstrate greater test-retest variance and to avoid repeat testing in all subjects at baseline, clinical trialists might consider repeating tests when RER < 1.05.Trial registration clinicaltrials.gov; Identifier: NCT00382863.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because the coefficient of variation of peak V˙o2 is ≈6% to 7% in older patients with HF,148,149 an increase of >7% from baseline suggests a clinically meaningful improvement in aerobic capacity.”
Citations
Cites
ATS/ACCP statement on cardiopulmonary exercise testing
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.2.211 · Cited by 3,026
ATS/ACCP statement on cardiopulmonary exercise testing
Ross, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.167.10.950 · Cited by 2,073
Kitzman, D. W. (2002) · JAMA · doi:10.1001/jama.288.17.2144 · Cited by 883
Arena, R., Myers, J., Williams, M. A., Gulati, M., Kligfield, P., Balady, G. J., Collins, E., & Fletcher, G. (2007) · Circulation · doi:10.1161/circulationaha.106.184461 · Cited by 727
Metabolic Acidosis during Exercise in Patients with Chronic Obstructive Pulmonary Disease
Sue, D. Y., Wasserman, K., Moricca, R. B., & Casaburi, R. (1988) · Chest · doi:10.1378/chest.94.5.931 · Cited by 354
Arena, R., Myers, J., & Guazzi, M. (2008) · Heart Failure Reviews · doi:10.1007/s10741-007-9067-5 · Cited by 268
Understanding the Basics of Cardiopulmonary Exercise Testing
Milani, R. V., Lavie, C. J., Mehra, M. R., & Ventura, H. O. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.12.1603 · Cited by 170
Bensimhon, D. R., Leifer, E. S., Ellis, S. J., Fleg, J. L., Keteyian, S. J., Piña, I. L., Kitzman, D. W., McKelvie, R. S., Kraus, W. E., Forman, D. E., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.04.047 · Cited by 116
Self-citationReproducibility of maximal exercise test data in the HERITAGE Family Study
SKINNER, J. S., WILMORE, K. M., JASKOLSKA, A., JASKOLSKI, A., DAW, E. W., RICE, T., GAGNON, J., LEON, A. S., WILMORE, J. H., RAO, D. C., et al. (1999) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199911000-00020 · Cited by 99
Piepoli, M. F., Corrà, U., AGOSTONI, P. G., Belardinelli, R., Solal, A. C., Hambrecht, R., & Vanhees, L. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/00149831-200602000-00003 · Cited by 92
Cited by
Fletcher, G. F., Ades, P. A., Kligfield, P., Arena, R., Balady, G. J., Bittner, V. A., Coke, L. A., Fleg, J. L., Forman, D. E., Gerber, T. C., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829b5b44 · Cited by 2,235
Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement
Puente-Maestu, L., Palange, P., Casaburi, R., Laveneziana, P., Maltais, F., Neder, J. A., O'Donnell, D. E., Onorati, P., Porszasz, J., Rabinovich, R., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00745-2015 · Cited by 412
Hansen, D., Abreu, A., Ambrosetti, M., Cornelissen, V., Gevaert, A., Kemps, H., Laukkanen, J. A., Pedretti, R., Simonenko, M., Wilhelm, M., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab007 · Cited by 321
“96 Thus, changes in exercise capacity below these values should not trigger adaptations in exercise prescription.”
BackgroundForman, D. E., Arena, R., Boxer, R., Dolansky, M. A., Eng, J. J., Fleg, J. L., Haykowsky, M., Jahangir, A., Kaminsky, L. A., Kitzman, D. W., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000483 · Cited by 319
Corrà, U., Agostoni, P. G., Anker, S. D., Coats, A. J. S., Crespo Leiro, M. G., de Boer, R. A., Harjola, V.-P., Hill, L., Lainscak, M., Lund, L. H., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.979 · Cited by 245
Relation Between Volume of Exercise and Clinical Outcomes in Patients With Heart Failure
Keteyian, S. J., Leifer, E. S., Houston-Miller, N., Kraus, W. E., Brawner, C. A., O’Connor, C. M., Whellan, D. J., Cooper, L. S., Fleg, J. L., Kitzman, D. W., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.958 · Cited by 204
Self-citationJCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E., Sato, K., Teramoto, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0002 · Cited by 191
Snoek, J. A., Prescott, E. I., van der Velde, A. E., Eijsvogels, T. M. H., Mikkelsen, N., Prins, L. F., Bruins, W., Meindersma, E., González-Juanatey, J. R., Peña-Gil, C., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2020.5218 · Cited by 155
Sachdev, V., Sharma, K., Keteyian, S. J., Alcain, C. F., Desvigne-Nickens, P. M., Fleg, J. L., Florea, V. G., Franklin, B. A., Guglin, M. E., Halle, M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001122 · Cited by 161
Self-citationKeteyian, S. J., Hibner, B. A., Bronsteen, K., Kerrigan, D., Aldred, H. A., Reasons, L. M., Saval, M. A., Brawner, C. A., Schairer, J. R., Thompson, T. M. S., et al. (2014) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000049 · Cited by 133
Self-citationBarreiro, E., Bustamante, V., Cejudo, P., Gáldiz, J. B., Gea, J., de Lucas, P., Martínez‐Llorens, J., Ruiz, F. Ó., Puente‐Maestu, L., Roca, J., et al. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2015.04.011 · Cited by 109
“En ensayos multicéntricos se ha demostrado que el T es reproducible 105,113 y consistente 105 (fig lim La diferencia clínicamente significativa para esta pruebas es del orden de 100s (intervalo de confianza del 95%: 50-150s) 113 4) Los diversos estudios demuestran consistentemente que la…”
Klompstra, L. V., Jaarsma, T., & Strömberg, A. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s90942 · Cited by 98
Chase, P. J., Kenjale, A. A., Cahalin, L. P., Arena, R. A., Davis, P. G., MYERS, J. N., Guazzi, M., Forman, D. E., Ashley, E. A., Peberdy, M. A., et al. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2013.05.008 · Cited by 76
D’Ascenzi, F., Cavigli, L., Pagliaro, A., Focardi, M., Valente, S., Cameli, M., Mandoli, G. E., Mueller, S., Dendale, P., Piepoli, M. F., et al. (2022) · British Journal of Sports Medicine · doi:10.1136/bjsports-2021-105261 · Cited by 69
Tegegne, T. K., Rawstorn, J. C., Nourse, R. A., Kibret, K. T., Ahmed, K. Y., & Maddison, R. (2022) · Open Heart · doi:10.1136/openhrt-2021-001949 · Cited by 65
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.02.014 · Cited by 68
Banks, A. Z., Mentz, R. J., Stebbins, A., Mikus, C. R., Schulte, P. J., Fleg, J. L., Cooper, L. S., Leifer, E. S., Badenhop, D. T., Keteyian, S. J., et al. (2016) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.12.007 · Cited by 56
Self-citationGhisi, G. L. D. M., Aultman, C., Konidis, R., Foster, E., Tahsinul, A., Sandison, N., Sarin, M., & OH, P. I. (2020) · Patient Education and Counseling · doi:10.1016/j.pec.2020.04.007 · Cited by 56
Sachdev, V., Sharma, K., Keteyian, S. J., Alcain, C. F., Desvigne-Nickens, P. M., Fleg, J. L., Florea, V. G., Franklin, B. A., Guglin, M. E., Halle, M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.02.012 · Cited by 48
Self-citationRose, G. A., Davies, R. G., Davison, G., Adams, R., Williams, I. M., Lewis, M. H., Appadurai, I. R., & Bailey, D. M. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.02.062 · Cited by 45
Keller, B. A., Receno, C. N., Franconi, C. J., Harenberg, S., Stevens, J., Mao, X., Stevens, S. R., Moore, G., Levine, S. M., Chia, J. K. S., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05410-5 · Cited by 43
“The marked differences in ICCs between phenotypes further substantiate the challenge of those with ME/CFS to reproduce CPET measures that are known to be highly reproducible in healthy [63], athletic [64], and diseased [65, 66] populations.”
BackgroundBarreiro, E., Bustamante, V., Cejudo, P., Gáldiz, J. B., Gea, J., de Lucas, P., Martínez‐Llorens, J., Ruiz, F. Ó., Puente‐Maestu, L., Roca, J., et al. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2015.04.027 · Cited by 68
Costanzo, M. R., Ivanhoe, R. J., Kao, A. S., Anand, I. S., Bank, A. J., BOEHMER, J. P., DeMarco, T., Hergert, C. M., Holcomb, R. G., Maybaum, S. W., et al. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.04.004 · Cited by 41
Self-citationHornsby, W., Norton, E. L., Fink, S., Saberi, S., Wu, X., McGowan, C. L. M., Brook, R. D., Jones, L. W., Willer, C. J., Patel, H. J., et al. (2019) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000446 · Cited by 37
Absence of Fitness Improvement Is Associated with Outcomes in Heart Failure Patients
Bakker, E. A., Snoek, J. A., Meindersma, E. P., Hopman, M. T. E., Bellersen, L., Verbeek, A. L. M., Thijssen, D. H. J., & Eijsvogels, T. M. H. (2017) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001429 · Cited by 40
“The threshold of 6% improvement was used to compensate for intertest variability, and an increase of V̇O2-peak of Q6% was considered a meaningful and reliable difference (12).”
MethodBussotti, M., Gremigni, P., Pedretti, R. F. E., Kransinska, P., Marco, S. D., Corbo, P., Marchese, G., Totaro, P., & Sommaruga, M. (2016) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x16666161130123937 · Cited by 33
Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities
Vacca, A., Wang, R., Nambiar, N., Capone, F., Farrelly, C., Mostafa, A., Sechi, L. A., & Schiattarella, G. G. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10439-1 · Cited by 33
“For comparison, an increase in peak VO 2 of 6–7% is considered clinically meaningful in patients with HFrEF [190, 191].”
Repeatability and Meaningful Change of CPET Parameters in Healthy Subjects
DeCato, T. W., Bradley, S. M., Wilson, E. L., & Hegewald, M. J. (2017) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001474 · Cited by 35
“Previous studies reported repeatability for peak O2 in patients with COPD (5, 6, 17, 18), cystic fibrosis (14), congestive heart failure (7, 10, 11, 15), and pulmonary arterial hypertension (9) with varied result (Table 5).”
BackgroundInfluentialLewis, G. D., Docherty, K. F., Voors, A. A., Solal, A. C., Metra, M., Whellan, D. J., Ezekowitz, J. A., Ponikowski, P. P., Böhm, M., Teerlink, J. R., et al. (2022) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.008970 · Cited by 28
Weemaes, A. T. R., Beelen, M., Bongers, B. C., Weijenberg, M. P., & Lenssen, A. F. (2021) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2021.04.016 · Cited by 26
De l’interprétation de l’exploration fonctionnelle d’exercice (EFX) à la décision médicale
Aguilaniu, B., & Wallaert, B. (2013) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2013.05.002 · Cited by 26
van Le, D., Jensen, G. V. H., Carstensen, S., & Kjøller‐Hansen, L. (2015) · Cardiology · doi:10.1159/000441292 · Cited by 24
Mirzai, S., Sandesara, U. B., Haykowsky, M. J., Brubaker, P. H., Kitzman, D. W., & Peters, A. E. (2025) · Heart Failure Reviews · doi:10.1007/s10741-025-10526-x · Cited by 22
“[49, 50].”
Smarż, K., Jaxa-Chamiec, T., Zaborska, B., Tysarowski, M., & Budaj, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184083 · Cited by 21
“These patients presented a decrease or increase in peak VO2 within the test–retest variability EC (±6%) [32].”
BackgroundMethodCoeckelberghs, E., Buys, R., Goetschalckx, K., Pattyn, N., Vanhees, L., & Cornelissen, V. (2016) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000158 · Cited by 21
Smith, K. N., Baynard, T., Fischbach, P., Hankins, J. S., Hsu, L. L.-Y., Murphy, P., Ness, K. K., Radom‐Aizik, S., Tang, A. Y., & Liem, R. I. (2021) · British Journal of Sports Medicine · doi:10.1136/bjsports-2021-104450 · Cited by 17
Nakanishi, M., Miura, H., Irie, Y., Nakao, K., Fujino, M., Otsuka, F., Aoki, T., Yanase, M., Goto, Y., & Noguchi, T. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13838 · Cited by 18
“3%) during the CCR programme among the 401 completers with available data for both changes; the median change in peak VO2 was nearly equal to the clinically meaningful value of 6%.(21,22) Patients who had a change in peak VO2 ≥ 6.”
MethodJakovljević, D. G., Seferovic, P. M., Nunan, D., Donovan, G., Trenell, M. I., Grocott-Mason, R. M., & Brodie, D. A. (2011) · Clinical Science · doi:10.1042/cs20110355 · Cited by 19
Bunæs-Næss, H., Kvæl, L. A. H., Nilsson, B. B., Heywood, S. E., & Heiberg, K. E. (2023) · BMJ Open Sport & Exercise Medicine · doi:10.1136/bmjsem-2023-001639 · Cited by 16
Perim, R. R., Signorelli, G. R., & de Araújo, C. G. S. (2011) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2011007500073 · Cited by 17
de Paiva, P. R. V., Casalechi, H. L., Tomazoni, S. S., Machado, C. D. S. M., Ribeiro, N. F., Pereira, A. L., de Oliveira, M. F. D., Alves, M. N. D. S., dos Santos, M. C., Takara, I. E. T., et al. (2020) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-020-00171-2 · Cited by 16
Bunsawat, K., Nelson, M. D., Hearon, C. M., & Wray, D. W. (2023) · Experimental Physiology · doi:10.1113/ep090674 · Cited by 16
“Indeed, meta-analyses of randomized supervised exercise training in HFpEF show an increase relative peak ̇ V O 2 of ∼ 12% (2 ml/kg/min), a clinically meaningful improvement (Keteyian et al., 2010; Nayor et al., 2020; Sachdev et al., 2023).”
BackgroundEvans, R. A., Dolmage, T. E., Robles, P., Goldstein, R. S., & Brooks, D. (2014) · CHEST Journal · doi:10.1378/chest.13-2060 · Cited by 14
Weemaes, A. T. R., Beelen, M., Weijenberg, M. P., van Kuijk, S. M. J., & Lenssen, A. F. (2024) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-024-01561-2 · Cited by 13
“[19] and is safe and feasible in patients with cancer [20].”
BackgroundFaricier, R., Keltz, R. R., Hartley, T., McKelvie, R. S., Suskin, N., Prior, P. L., & Keir, D. A. (2023) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000837 · Cited by 14
Cardiopulmonary exercise testing criteria for advanced therapies in patients with heart failure
Brawner, C. A., & Lazar, M. H. (2023) · Heart Failure Reviews · doi:10.1007/s10741-023-10337-y · Cited by 11
“1 3 procedures [11], the coefficient of variation of various CPET variables among patients with HFrEF is 4–10% [12].”
BackgroundSelf-citationLeft ventricular diastolic dysfunction and exertional ventilatory inefficiency in COPD
Müller, P. D. T., Utida, K. A. M., Augusto, T. R. D. L., Spreafico, M. V. P., Mustafa, R. C., Xavier, A. C. W., & Saraiva, E. F. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.10.014 · Cited by 11
de Paiva, P. R. V., Casalechi, H. L., Tomazoni, S. S., Machado, C. D. S. M., Miranda, E. F., Ribeiro, N. F., Pereira, A. L., da Costa, A. S., Dias, L. B., Souza, B. C. G., et al. (2019) · Medicine · doi:10.1097/md.0000000000015317 · Cited by 11
“Ergospirometry is currently the most accurate cardiorespiratory fitness test.([24]) In this study, we will use a progressive treadmill protocol, previously used by our research group,([5,7,17]) an ergometric treadmill model Super ATL, and a gas analyzer model VO2000 (Inbrasport, Porto Alegre - RS, Brazil), which will…”
MethodVentilatory inefficiency during graded exercise in COPD: A pragmatic approach
Müller, P. D. T., & Saraiva, E. F. (2020) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12674 · Cited by 11
“Thus, as previously reported, a mean absolute difference of 2.5 and a withinsubject SD of 1.7 for V´E-V´CO2 slope (Keteyian et al., 2010) in an unpaired design proved that n = 10 in each group was an acceptable number of subjects to reach a power of 0.82% with an α = 0.05.”
BackgroundInfluentialTørhaug, T., Brurok, B., Hoff, J., Helgerud, J., & Leivseth, G. (2017) · Topics in Spinal Cord Injury Rehabilitation · doi:10.1310/sci17-00029 · Cited by 9
Calegari, L., Moreira, I., Falkowski, A., Reolão, J. B. C., Karsten, M., & Deresz, L. F. (2021) · Journal of Exercise Rehabilitation · doi:10.12965/jer.2142488.244 · Cited by 8
Trainability for cardiopulmonary fitness is low in patients with peripheral artery disease
Huang, S., Yeh, C., Hsu, C., Lin, Y., Lee, C., Hsiao, C.-C., Chiu, C., & Fu, T. (2023) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvad044 · Cited by 9
Chen, C., Wang, J., Lin, M., Chiu, H.-H., Hsu, J., Lin, S., Chang, Y., Chiu, S., Lu, C., Wu, M., et al. (2020) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.119.008813 · Cited by 8
Okwose, N. C., Zhang, J., Chowdhury, S., Houghton, D., Ninkovic, S. M., Jakovljević, S., Jevtić, B., Ropret, R., Eggett, C. J., Bates, M. G. D., et al. (2019) · International Journal of Sports Medicine · doi:10.1055/a-0809-5408 · Cited by 6
Determinants of V̇+O2peak Changes After Aerobic Training in Coronary Heart Disease Patients
Girault, A., Leprêtre, P., Trachsel, L. D., Besnier, F., Boidin, M., Lalongé, J., Juneau, M., Bherer, L., Nigam, A., & Gayda, M. (2024) · International Journal of Sports Medicine · doi:10.1055/a-2253-1807 · Cited by 5
“U nau t ho r i z ed d i s t r i bu t i on i s s t r i c t l y p r oh i b i t ed . ed 12 to 61 % of the patients engaged in ECR programs [4, 5, 15, 24].”
BackgroundMethodInfluentialWindhaber, J., Steinbauer, M., Holter, M., Wieland, A., Kogler, K., Riedl, R., Schober, P. H., Castellani, C., Singer, G., & Till, H. (2021) · European Journal of Applied Physiology · doi:10.1007/s00421-021-04601-y · Cited by 6
Wohlfahrt, P., Jenča, D., Melenovský, V., Mrázková, J., Šramko, M., Kotrč, M., Želízko, M., Adámková, V., López-Jiménez, F. A., Pitha, J. V., et al. (2024) · Mayo Clinic Proceedings Digital Health · doi:10.1016/j.mcpdig.2024.06.001 · Cited by 6
“15 Furthermore, the 10% V O 2peak improvement is beyond the 5.9% coef fi cient of variation for V O 2peak assessment 16 and, thus, can be classi fi ed as genuine.”
InfluentialKarisa, P., Sylviana, N., Syamsunarno, M. R., FItria, N., Tiksnadi, B. B., & Setiawan, S. (2026) · Patient Preference and Adherence · doi:10.2147/ppa.s581645 · Cited by 5
Carlisle, J. B. (2013) · Anaesthesia · doi:10.1111/anae.12343 · Cited by 3
“in the same cohort [16]: one would expect 95% of repeated measure-”
BackgroundKoen, M., Kubota, Y., Tokita, M., Kato, K., Takahashi, H., Akutsu, K., Asai, K., & Takano, H. (2023) · Heart and Vessels · doi:10.1007/s00380-023-02289-y · Cited by 3
de Campos, G. G. O., Goelzer, L. S., Augusto, T. R. D. L., Barbosa, G., Chiappa, G. R., Iterson, E. H. V., & Müller, P. D. T. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20230578 · Cited by 4
Weemaes, A. T. R., Meijer, R., Beelen, M., van Hooff, M., Weijenberg, M. P., Lenssen, A. F., van de Poll-Franse, L. V., Savelberg, H. H. C. M., & Schep, G. (2023) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-023-00613-8 · Cited by 3
Observed change in peak oxygen consumption after aortic valve replacement and its predictors
Le, V. D. T., Jensen, G. V. H., & Kjøller‐Hansen, L. (2016) · Open Heart · doi:10.1136/openhrt-2015-000309 · Cited by 2
Patient-reported questionnaires to preoperatively identify high-risk surgical patients
Meijer, R., ten Cate, D. W. G., Bongers, B. C., Regis, M., Savelberg, H. H. C. M., Slooter, G. D., Janssen, S., van Hooff, M., & Schep, G. (2024) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-024-03560-0 · Cited by 1
VO2Peak: The Emerging End Point For Cardiovascular Outcome Trials in Nephrology
Lim, K. J., Campos, M. O., & Moe, S. M. (2025) · Kidney360 · doi:10.34067/kid.0000001106 · Cited by 1
“38 Each of these tests provides important clinical and complementary value.”
Exercise Standards for Testing and Training: A Scientific Statement From the American
Rhodes, J., Thompson, P. D., Williams, M. A., Coke, L. A., Fleg, J. L., Forman, D. E., Gerber, T. C., Gulati, M., Fletcher, F. M., Ades, P. A., et al. (2013) · Cited by 1
Nakamura, H., Hashimoto, K., Takahashi, K., & Matsuda, H. (2020) · Oral Health & Dental Science · doi:10.33425/2639-9490.1051 · Cited by 1
“Combining knowledge gained form CPX, highly repeatable and objective information on the overall health of an individual can be obtained [5,6].”
BackgroundMind or Body: Comment on “Tai Chi Exercise in Patients With Chronic Heart Failure”
Teerlink, J. R. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.92 · Cited by 1
Tatsuki, H., Yasuhiro, N. O. M. A., Kawabata, M., KAWAHARA, T., Naoi, D., Shimada, R., Mibu, K., AIZAWA, T., & Iseki, H. (2016) · JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE · doi:10.2185/jjrm.65.202
Evaluation of the effect of interventions on exercise capacity in pulmonary patients
Puente‐Maestu, L. (2019) · Minerva Pneumologica · doi:10.23736/s0026-4954.18.01833-3
Repeatability of tidal expiratory flow limitation during peak exercise
(2025) · The Journal of Sport and Exercise Science · doi:10.36905/jses.2025.02.01
Kitayama, T., Mikami, K., Tsuji, T., Sukawa, M., Tajima, A., Maruyama, Y., & Harada, T. (2025) · Physiotherapy Research International · doi:10.1002/pri.70137
“A value of 6% has been reported to be associated with prognosis in patients with heart failure, and it is considered to fall within the range of physiological variation (Corrà et al. 2006; Keteyian et al. 2010; Swank et al. 2012).”
Weemaes, A. T. R., Beelen, M., Weijenberg, M. P., van Kuijk, S. M. J., & Lenssen, A. F. (2024) · Figshare · doi:10.6084/m9.figshare.26673030
Weemaes, A. T. R., Beelen, M., Weijenberg, M. P., van Kuijk, S. M. J., & Lenssen, A. F. (2024) · Figshare · doi:10.6084/m9.figshare.26673027
Weemaes, A. T. R., Beelen, M., Weijenberg, M. P., van Kuijk, S. M. J., & Lenssen, A. F. (2024) · Figshare · doi:10.6084/m9.figshare.26673024
Tjelesna aktivnost – kardiovaskularna panaceja
Gulin, D., & Šikić, J. (2019) · Hrčak Portal of scientific journals of Croatia (University Computing Centre)
Ordosch, M. (2017) · Dokumentenrepositorium der RUB (Ruhr University Bochum)
Lee, Y., Feng, J., Rahrooh, A., Bui, A. A. T., Cooper, C. B., & Hsu, J. J. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.045734
Arima, Y., Kaihara, T., Nakamura, M., Sone, K., Yoshida, T., Utsugi, Y., Takizawa, S., Doi, S., Honda, K., Kobayashi, Y., et al. (2026) · JMIR Cardio · doi:10.2196/85808
“The observed increase exceeded the minimum clinically meaningful difference of 1 mL/kg/min for reducing mortality risk [24].”
Metadata
- Authors
- Keteyian, S. J., Brawner, C. A., Ehrman, J. K., Ivanhoe, R., Boehmer, J. P., & Abraham, W. T.
- Affiliations
- Henry Ford Hospital (US)
- Pennsylvania State University (US)
- The Ohio State University Wexner Medical Center (US)
- Corresponding author
- Keteyian, Steven J.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 138
- Issue
- 4
- Pages
- 950-955
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2128837393
- Cited by
- 75
- References
- 18
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 10 · 2023: 9 · 2022: 4 · 2021: 6 · 2020: 6 · 2019: 4 · 2018: 2 · 2017: 5 · 2016: 5 · 2015: 5 · 2014: 2 · 2013: 6 · 2012: 2
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Keywords
- peak oxygen uptake, test-retest reproducibility, coefficient of variation, cardiopulmonary exercise testing, ventilatory efficiency, anaerobic threshold, respiratory exchange ratio, heart failure, exercise capacity, quality assurance
- MeSH terms
- Exercise Test, Female, Heart Failure, Humans, Male, Middle Aged, Oxygen Consumption, Quality of Life, Reproducibility of Results, Chi-Square Distribution, Walking, Prostheses and Implants, Endpoint Determination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.